CapMan Russia acquires 25% of Vital Development Company

Earlier this month, CapMan Russia exited Russian telecommunications firm Tascom for an estimated selling price of $80-90m.

The company had planned an IPO on the Moscow Stock Exchange in 2011, but canceled it due to poor market conditions. The public offering would have valued Vital at RUB 1.7-2.6bn. The company's financial adviser Finam introduced CapMan to the management team.

Company
Vital is a St Petersburg-based developer and producer of equipment for laboratory analysis. Its product range includes biochemical and immunological reagent test sets and analysers. Vital mainly caters to the Russian market, while exports to CIS and other countries make up about 20% of its sales. Founded in 1994, the company employs 90 people. In 2011, the company's turnover exceeded €6m.

People
Alexander Vlasov, partner, led the deal on behalf of CapMan Russia. Alexander Plekhov is executive director of Vital.

Advisers
Equity – Castren & Snellman, Sergei Lee (Legal); University of Tromsø, Ørjan Olsvik (Technical due diligence); Branan, Anna Gurevich (Environmental due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• CEE
• Healthcare
• Buyouts
• Russia
• IPO